LINC01517

Across TCGA pan-cancer cohorts, LINC01517 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC01517 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LINC01517 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01517 expression acts as an unfavorable survival marker, although some lineages such as OV and BLCA show a favorable association.

SKCM, BRCA, and CESC are the cancer types where LINC01517 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.524	0.753	<.001	87	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	72	view →
CESC	OS	Tertile	III,IV	0.395	0.787	.001	72	view →
OV	DFS	Tertile	All	0.262	0.150	.019	54	view →
BLCA	OS	Tertile	All	0.545	0.381	.002	53	view →
ACC	OS	Tertile	II,III,IV	0.494	0.832	.004	45	view →
LIHC	DFS	Tertile	II,III,IV	0.205	0.508	.002	27	view →
READ	DFS	Tertile	II,III,IV	0.685	0.823	.021	23	view →
LGG	OS	Tertile	All	0.210	0.493	.001	12	view →
ESCA	OS	Median	III,IV	0.575	0.322	.011	11	view →
PCPG	DFS	Tertile	All	0.236	0.872	<.001	9	view →
TGCT	DFS	Tertile	II,III,IV	0.662	1.000	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC01517–SKCM (DFS)

Open the SKCM breakdown →